Ann: Company Update, page-57

Nah mate. Again, standard practice for specs to refresh their 10% capacity, so they end up with 15% (LR 7.1) + 10% (LR 7.1A) for the year ahead, without needing s/h approval.

Geez, a bio or anything medical (and no Ch1&2) would be mouthwatering! Then again, hearing cryptos are starting to catch a few bids again. SMX also did 150% in under two weeks from IPO. ID8 ok, without being great. Tymlez IPO coming up and some see that doing ok too.